APA (7th ed.) Citation

A, M., D, F., MB, B., P, A., C, B., J, G., . . . FGB, d. Q. (2022). Immunogenicity induced by the use of alternative vaccine platforms to deal with vaccine shortages in a low- to middle-income country: Results of two randomized clinical trials. Lancet regional health. Americas, 9, 100196. https://doi.org/10.1016/j.lana.2022.100196

Chicago Style (17th ed.) Citation

A, Macchia, et al. "Immunogenicity Induced by the Use of Alternative Vaccine Platforms to Deal with Vaccine Shortages in a Low- to Middle-income Country: Results of Two Randomized Clinical Trials." Lancet Regional Health. Americas 9 (2022): 100196. https://doi.org/10.1016/j.lana.2022.100196.

MLA (9th ed.) Citation

A, Macchia, et al. "Immunogenicity Induced by the Use of Alternative Vaccine Platforms to Deal with Vaccine Shortages in a Low- to Middle-income Country: Results of Two Randomized Clinical Trials." Lancet Regional Health. Americas, vol. 9, 2022, p. 100196, https://doi.org/10.1016/j.lana.2022.100196.